The new manufacturing deal will see ADL BioPharma – a subsidury of ADL Bionatur – dedicate a part of its fermentation capacity to the supply of Fermentalg’s high-DHA algal oil known as DHA Origins-550 for several years as the company looks to ensure adequate supple in the face of growing demand.
News of the production partnership comes just days after Fermentalg signed a deal for the distribution of high-potency omega-3 products with global ingredients supplier DSM. That deal saw Fermentalg grant exclusive rights to DSM for selling its high-potency DHA products in certain market segments. At the time the company said the ‘ground breaking’ five-year contract will accelerate penetration of its high-potency Origins DHA ingredient.
Further partnership
On the back of the DSM deal, Fermentalg now says it needs to ensure a higher supply of its algal oil.
“This long-term contract, following the signature of a major commercial partnership, secures our supply of our high value DHA Origins 550, the algal DHA with the highest natural concentration on the market,” commented Philippe Lavielle, CEO of Fermentalg – adding that ADL BioPharma’s scale, experience and capabilities match his company’s commitment “to become one of the world’s largest producers of algal DHA.”
Pilar de la Huerta, CEO of ADL BioPharma, added that the deal is the fourth long-term manufacturing contract the Spanish firm has signed in the last ten months, “securing more than 85% of our fermentation capacity for the next several years and demonstrating the market need for state-of-the-art industrial fermentation sites.”